Pricing transparency is an issue that will not got away and pharma must actively engage if it is to influence the debate. That is why in Pricing Transparency in Pharma we interviewed experts to help you understand the current drive for price transparency, the countries and organisations leading the debate and the strategies that can prepare pharma to comply and engage.
Pricing experts explore the health insurance landscape
- Will there be more legislative action on drug price transparency in the future and what are the prospects for legislation convergence
How best can manufacturers monitor the countries and organisations that are shaping the drug price transparency debate?
- How should manufacturers take into account price reporting in future pricing strategy for new product launches and existing products?
- How might drug price transparency impact pricing strategies?
- What will be the impact of drug price transparency on price, access, R&D and reputation of the industry